Next Health weighs the pros and cons to help you make informed decisions.Read to learn more today
Semaglutides SUSTAIN-6 trial demonstrated a significant reduction in major adverse cardiovascular events in adults with type 2 diabetes, along with improvements in body weight and HbA1c (NCBI Bookshelf)
It's about whether or not oil can actually move
"Our approach emphasizes stewardship of the entire treatment continuum, from start through maintenance, with a clear clinical framework for when therapy can be safely reduced and, when appropriate, discontinued. Today, there is no clear standard for how long patients should stay on GLP-1s or how to safely come off
Her work ensures clients benefit plans are built accurately, a vital piece of pharmacy benefit management
Circ Res 83:366377 Shaw CF, Savas MM, Petering DH (1991) Ligand substitution and sulfhydryl reactivity of metallothionein